IN VITRO ANTICANCER POTENTIAL OF STATIN FROM ASPERGILLUS TAMARII GRD119
Objectives: Fungi have been largely targeted for their biopotential mainly in pharmaceutical industry. Recently, there has been an increase in screening of biopharmaceuticals from microorganisms so as to eliminate side-effects and chemical damages from non-natural sources.
Methods: In the present study, Aspergillus tamarii GRD119 (JX110981) was screened for the production of statin by conducting bioassays against Candida and filamentous fungi.
Results: Based on the results obtained showing effective inhibition potential against Candida spp and A. fumigatus, further analysis of purification of statin by several chromatographic analyses such as column chromatography, TLC, HPTLC and HPLC was conducted. The extracted statin shows strong cytotoxic activity against HEP G2 cell line.
Conclusions: These results designate the fungal strain and the statin produced can serve as candidates for potential genetic transformation and further structural analysis respectively.
Keywords: Aspergillus tamarii, chromatography, purification, statin, cytotoxicity.
2. Nicholls SJ, Sipahi I, Schoenhagen P, Crowe T, Tuzcu EM, Nissen SE. Application of intravascular ultrasound in anti-atherosclerotic drug development. Nat Rev Drug Discov 2006;5(6):485-492.
3. Galgoczy L, Nyilasi I, Papp T, Vagvolgyi C. Statins as antifungal agents. World J Clin Infect Dis 2011;1(1): 4-10.
4. Barrios-GonzÃ¡lez J, Miranda RU. Biotechnological production and applications of statins. Appl Microbiol Biotechnol 2010;85(4):869-883.
5. Ahmad A, Panda BP, Khan SA, Javed S. Downstreaming and purification of lovastatin from Monascus purpureus culture. TJPS 2009;33:39-4.
6. Saito M, Machida S. A rapid identification method for aflatoxin producing strains of Aspergillus flavus and A. parasiticus by ammonia vapor. Mycosci 1999;40(2):205-208.
7. Macreadie GI, Johnson G, Schlosser T, Macreadie PI. Growth inhibition of Candida species and Aspergillus fumigates by statins. FEMS Microbiol Lett 2006;262:9â€“13.
8. Skoog DA, Holler FJ, Nieman TA. Separation methods. In: Principles of Instrumental Analysis, Saunders College Publishing, Philadelphia, USA, pp. 674-700 1998.
9. Hajko P, Wildman A. Process for purification of HMG-CoA reductase inhibitors. U.S. Patent. 1993;5:202-029.
10. Siamak SM, Moazami N, Haghighi S, Aziz Mohseni F, Mirdamadi S, Bakhtiari MR. Screening of Lovastatin Production by Filamentous Fungi. Iran Biomed J 2003;7(1): 29-33.
11. Badiee P, Alborzi A. Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study. Iran J Microbiol 2011;3(4):183.
12. Mahmoudabadi AZ, Zarrin M, Fard MB. Antifungal Susceptibility of Candida Species Isolated From Candiduria. Jundishapur J Microbiol 2013;6(1):24-28.
13. Chin NX, Weitzman I, Della-Latta P. In vitro activity of ï¬‚uvastatin, a cholesterol-lowering agent, and synergy with ï¬‚ucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother 1997;41:850â€“852.
14. Sree Devi K, Rao VJ, Lakshmi NM, SaiKrishna K. Isolation and screening of lovastatin producing Aspergillus terreus fungal strains from soil samples. Int J Pharm Technol 2011;3(2):2772-2782.
15. Himakiran BR, Rupa A, Radha S, Prasad NBL, Narasimha G. Screening of lovastatin producing fungi by yeast growth inhibition assay method. J Pharm Res 2011;4(9):2967-2968.
16. Mangunwardoyo W, Rafliyanti Y, Kusmana D. Bioprospect of lovastatin in Aspergillus spp from university of indonesia culture collection (UICC). World Appl Sci J 2012;16(2):183â€“188.
17. Srinu M, Phani Bhushan P, Srilakshmi SP, Lakshminarayana K. Screening of HMG COA reductase inhibitor producing marine actinomycetes. J Pharm Res Health Care. 2010;2(1):166 -74.
18. Kshirsagar VB, Deokate UA, Bharkad VB, Khadabadi SS. HPTLC Method Development and Validation for the simultaneous Estimation of Diosgenin and Levodopa in marketed formulation. Asian J Res Chem 2008;1:36-39.
19. Lakshmanan D, Radha KV. An effective quantitative estimation of lovastatin from Pleurotus ostreatus using UV and HPLC. Int J Pharm Pharm Sci 2012;4(4):462-464.
20. Jahromi MF, Liang JB, Ho YW, Mohamad R, Goh YM, Shokryazdan P. Lovastatin production by Aspergillus terreus using agro-biomass as substrate in solid state fermentation. J Biomed Biotechnol 2012;196264:11.
21. Seydametova E, Salihon J, Norazwina Z, Convey P. Production of Lovastatin by Penicillium spp Soil Microfungi. Int J Chem Eng Appl 2012;3-5.
22. Eyad SM, Nameh A, Reyad AS, Ali A. High-Performance Liquid Chromatographic Determination of Simvastatin in Medical Drugs. J Anal Chem 2006;66(1):63â€“66.
23. Praveen Kumar SN, Gowda BDG. Development and Validation of HPLC Method for the Determination of Simvastatin in Bulk and Pharmaceutical Formulation. J Chem Pharma Res 2012;4(5):2404-2408.
24. Kublin E, Malanowicz EWA, Kaczmarska-graczyk B, Aleksander P. Development of chromatographic method for determination of drugs reducing cholesterol level. Acta Pol Pharm Drug Res 2012;69(139):143.
25. Yang DJ, Hwang LS. Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea. J Chromatogr 2006;1119:277â€“284.
26. Praveen Kumar S, Gowda BNA, Vathsala DC, Mantelingu KB, Rangappa K. Simultaneous estimation of statins like pravastain, atorvastatin and simvastatin in bulk and pharmaceutical dosage form by means of High-Performance Liquid Chromatography. J Chem Pharm Res 2013;5(5):359-364.
27. Werner M, Sacher J, Hohenegger M. Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol 2004;143:715-724.
28. Sadeghi-Aliabadi H, Minaiyan M, Dabestan A. Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells. Res Pharm Sci 2010;5(2):127.
29. Schmidmaier R, Simsek M, Baumann P, Emmerich B, Meinhardt G. Synergistic antimyeloma effects of zoledronate and simvastatin. Anti-cancer Drugs 2006;17:621-629.
30. Wong WWL, Tan MM, Xia Z, Dimitroulakos J, Minden MD, Penn LZ. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clin Cancer Res 2001;7(7):2067-2075.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.